6 Biotech Stocks to Buy Now Ahead of These June Catalysts
nasdaq.com
news
2022-06-03 17:11:00

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

The market is beginning to turn the corner after a very uninspiring performance in most of the first half. Logic dictates that the rebound will likely be led by beaten-down sectors and stocks. On that count, pharma and biotech stocks are ideal candidates for a stronger recovery, given their underperformance relative to the broader market over the past year and a half.

Any potential recovery in biotechs will become sustainable only if the anticipated technical bounceback is supported by fundamentals.
